Monocenter studies

Numerous renowned German and international clinics are currently conducting monocentric scientific studies on the efficacy and clinical effects of CytoSorb use in a wide range of hyperinflammatory conditions.

Examines are e.g. the consequences of cardiopulmonary bypass, septic shock or severe acute pancreatitis. Several studies on other applications such as burns or liver failure are in the pipeline. In total, more than 50 investigator-initiated trials are in progress, of which approximately 20 are already actively recruited and 4 completed. The remaining studies are at different stages of preparation and implementation.

As some of these projects are currently nearing completion or have already been completed, we expect to see a significant increase in published evidence on the effectiveness and clinical outcomes of CytoSorb therapy over the next few months.

As further studies begin with the inclusion phase, they will be listed here.

Overview of currently running monocenter study projects: